Clinical Trials Directory

Trials / Sponsors / Revimmune

Revimmune

Industry · 8 registered clinical trials.

StatusTrialPhaseStarted
TerminatedInterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort)
COVID-19, Lymphocytopenia
Phase 22021-03-01
TerminatedInterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O )
COVID-19, Lymphocytopenia
Phase 22020-12-20
TerminatedRecombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lung Disease
Mycobacterium Infections, Nontuberculous
Phase 22020-11-30
TerminatedInterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I )
COVID-19, Lymphocytopenia
Phase 22020-09-15
TerminatedInterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort
COVID-19, Lymphocytopenia
Phase 22020-06-08
TerminatedInterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort
COVID-19, Lymphocytopenia
Phase 22020-05-14
TerminatedRecombinant Interleukin-7 (CYT107) to Restore Absolute Lymphocyte Counts in Sepsis Patients
Sepsis, Severe
Phase 22019-06-01
CompletedA Study of IL-7 to Restore Absolute Lymphocyte Counts in Sepsis Patients
Severe Sepsis With Septic Shock
Phase 22016-01-01